There was a significant negative correlation between the concentrations of EPA or DHA and the severity of CAD in patients with higher AMPKα2 levels (AMPKα2 ≥ 8.2 pg/mL, n = 135) (Fig. 7F, G). The gene discussed is PRKAA2; the disease is coronary artery disorder.